Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.

Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife Alliance's Frozen Zoo.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...

Illumina Inc. was hit with an antitrust lawsuit on Sept. 22 in California Northern District Court over alleged anticompetitive practices in the DNA sequencing market. The action, brought by Quinn ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Once I hit middle age, I became ruthless about preserving the ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...

The Illumina Campus in San Diego. (File photo courtesy of the company) Illumina said Wednesday the Chinese Ministry of Commerce will lift its ban on imports of the San Diego company’s gene sequencers ...

Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country. The move is a reversal from China’s previous position, which blocked ...